Evidence map›Paper›PMID 26884826›Full record

ArticleInternational journal of clinical and experimental pathology2015

Changes in focal adhesion kinase expression in rats with collagen-induced arthritis and efficacy of intervention with disease modifying anti-rheumatic drugs alone or in combination.

Hui-Ying Gao, Jing Luo, Xiao-Feng Li, Qian Lv, Hong-Yan Wen, Qing-Zhen Song, Wen-Peng Zhao, Xiang-Cong Zhao, Ting-Ting Zhang, Si-Yu Zhang and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hui-Ying GaoDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Jing LuoDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Xiao-Feng LiDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Qian LvDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Hong-Yan WenDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Qing-Zhen SongDepartment of Medicine, Shanxi Tumor Hospital Taiyuan 030013, Shanxi, China.
Wen-Peng ZhaoDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Xiang-Cong ZhaoDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Ting-Ting ZhangDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Si-Yu ZhangDepartment of Rheumatology, The Second Hospital, Shanxi Medical University Taiyuan 030001, Shanxi, China.
Jian-Ming ZhiDepartment of Physiology, School of Medicine, Shanghai Jiaotong University Shanghai 200025, China.
Shanxi Medical University · CNShanghai Jiao Tong University · CNShanxi Provincial Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal adhesion kinase (FAK) is known to promote the proliferation, migration and survival of synovial cells and plays an important role in the occurrence, development and pathological process of rheumatoid arthritis (RA). The aim of the present study was to observe FAK changes in synovial cells of rats with collagen-induced arthritis (CIA) and after intervention with disease modifying anti-rheumatic drugs (DMARDs) alone or in combination in a CIA female SD rat model induced by collagen type II. The rats were randomized to 8 groups: normal control group, CIA model control group, methotrexate (MTX, 0.9 mg/kg/w) group, cyclophosphamide (CTX, 24 mg/kg/3 w) group, leflunomide (LEF, 1.2 mg/kg/d) group, MTX + CTX group, LEF + CTX group, and MTX + LEF group. They were intervened with DMARDs alone or in combination for six weeks. The experiment lasted a total of 9 weeks in vivo. Articular inflammation was measured during the process of drug intervention in terms of the degree of swelling degree in the right hind foot using a venire caliper. All animals were sacrificed by breaking the neck after 9 weeks. Then, the ankle was fixed, decalcified, embedded, and HE stained, and prepared into slices to observe pathological changes in the synovial tissue. FAK expression in synovial cells was assayed by immunohistochemistry and the mean optical density (OD) value was measured using the HPIAS-2000 image analysis system. It was found that FAK expression was negative in normal control group, positive in CIA model control group, and decreased in the three DMARD combination treatment groups significantly as compared with that in the three single-drug groups (P < 0.05). FAK expression in LEF + CTX group or MTX + CTX group decreased more significantly than that in MTX + LEF group (P < 0.05), and there was no statistically significant difference between LEF + CTX and MTX + CTX groups. The arthritis index and pathological change in the synovial tissue in LEF + CTX group or MTX + CTX group were improved more significantly than those in MTX + LEF group or single-drug groups. Our results showed that FAK expression was positive in CIA rats, indicating that it played an important role in the pathogenesis of RA, and that intervention with DMARDs could reduce the FAK expression in synovial cells of CIA rats. We hope these findings would contribute to the treatment of RA and other rheumatic diseases by reducing adhesion, proliferation and migration of synovial cells and inhibiting the over-expression of FAK.

Indexed as

Collagen Type IIAnimalsAntirheumatic AgentsArthritis, ExperimentalCyclophosphamideDrug Therapy, CombinationFemaleFocal Adhesion Kinase 1IsoxazolesJointsLeflunomideMethotrexateRats, Sprague-DawleySynovial MembraneTime FactorsAntirheumatic AgentsCollagen Type IICyclophosphamideFocal Adhesion Kinase 1IsoxazolesLeflunomideMethotrexatePtk2 protein, ratcollagen-induced arthritisdisease modifying anti-rheumatic drug (DMARD)Focal adhesion kinaserheumatoid arthritis (RA)

Identifiers

PMID26884826
PMCPMC4730039
OpenAlexW2411985122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.